Comparison of Nucleoside Reverse Transcriptase Inhibitor Use as Part of First-Line Therapy in a Serbian and a UK HIV Clinic

Abstract

Patients treated at HCB faced higher levels of mitochondrial-related toxicity, likely due to greater dNRTI use.